BackWakamoto Pharmaceutical ,Ltd. Overview

Wakamoto Pharmaceutical ,Ltd. Total Liabilities

Latest total liabilities for 4512.T: $4.1B.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$4.15B
↑ 26.12% YoYΔ $859.30M vs prior year quarter

Peer trimmed avg / median

Loading

Wakamoto Pharmaceutical ,Ltd. Total Liabilities History

Loading

Wakamoto Pharmaceutical ,Ltd. vs. peers: Total Liabilities Comparison

Loading

Wakamoto Pharmaceutical ,Ltd. Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Wakamoto Pharmaceutical ,Ltd. (4512.T) FAQ

Wakamoto Pharmaceutical ,Ltd. (4512.T) currently reports a total liabilities of $4.1B as of September 2026. That compares with $3.3B in the prior-year period — up 26.1% year over year. Use the charts on this page to explore Wakamoto Pharmaceutical ,Ltd.'s total liabilities history and peer comparisons.

Wakamoto Pharmaceutical ,Ltd.'s total liabilities increased from $3.3B to $4.1B — a 26.1% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Wakamoto Pharmaceutical ,Ltd. reported $4.1B in total liabilities as of September 2026. That compares with $3.3B in the prior-year period — up 26.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $4.1B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Wakamoto Pharmaceutical ,Ltd., and consider following 4512.T for alerts when major investors trade the stock.